TABLE 3.

Crude and adjusted OR (with 95% CI and “p” values) for different somatometric measurement methods in regard to primary end-points occurrence (mortality, ICU admission, and either primary end-point).

Somatometric measurement method	Body composition categories	End-point occurrence (%)	Crude OR (95% CI)	P	Adjusted OR* (95% CI)	P
Mortality
BMI	Non-obese	13%	1		1
	Obese	22.4%	1.930 (0.939–3.971)	0.075	2.387 (1.067–5.337)	0.034
BF%	Non-obese	10.4%	1		1
	Obese	22.7%	2.540 (1.179–5.470)	0.017	3.353 (1.471–6.642)	0.004
VF	Normal/High	10.5%	1		1
	Very high	22.6%	3.066 (1.466–6.411)	0.003	3.050 (1.407–6.609)	0.005
Critical form
BMI	Non-obese	22.1%	1		1
	Obese	51.8%	3.775 (2.087–6.827)	0.001	3.113 (1.663–5.825)	0.001
BF%	Non-obese	13.2%	1		1
	Obese	53.6%	7.602 (3.868–14.960)	0.001	7.141 (3.538–14.413)	0.001
VF	Normal/High	26.3%	1		1
	Very high	56.8%	2.364 (1.325–4.219)	0.004	3.424 (1.781–6.581)	0.001
Composite outcome
BMI	Non-obese	25.2%	1		1
	Obese	51.8%	3.187 (1.784–5.693)	0.001	2.769 (1.495–5.125)	0.001
BF%	Non-obese	16%	1		1
	Obese	54.5%	6.282 (3.312–11.918)	0.001	6.085 (3.121–11.862)	0.001
VF	Normal/High	27.8%	1		1
	Very high	48.2%	2.414 (1.360–4.284)	0.003	3.208 (1.705–6.035)	0.001

% BF, Body fat percentage; BMI, Body mass index; CI, Confidence interval; ICU, Intensive care unit; OR, odds ratio; VF, Visceral fat.

OR values with a statistical significance level of <0.05 are presented in bold.

*OR was adjusted for age, sex, days from disease onset, and diabetes mellitus.